Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.3K
Ligand Binding Sites02:40

Ligand Binding Sites

8.9K
8.9K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.2K
4.2K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.3K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.3K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.7K
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards better structural models from cryo-electron microscopy data with physics-based methods.

FEBS letters·2025
Same author

OpenMM 8: Molecular Dynamics Simulation with Machine Learning Potentials.

The journal of physical chemistry. B·2023
Same author

Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding Affinities of GPCR Complexes via Induced Fit Docking and Free Energy Perturbation.

Journal of chemical theory and computation·2023
Same author

Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2.

Proceedings. Biological sciences·2021
Same author

Insights on cross-species transmission of SARS-CoV-2 from structural modeling.

PLoS computational biology·2020
Same author

PDB-tools web: A user-friendly interface for the manipulation of PDB files.

Proteins·2020

Related Experiment Video

Updated: Feb 17, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.3K

Accurate Physics-Based Flexible Docking of Macrocyclic Ligands.

Jacob Robson-Tull1, João P G L M Rodrigues1

  • 1Schrodinger New York, 1540 Broadway, 24th Floor, New York, New York 10035, United States.

Journal of Medicinal Chemistry
|February 16, 2026
PubMed
Summary

A new computational modeling protocol enhances the accuracy of macrocycle drug discovery. This flexible docking method effectively predicts how macrocyclic compounds bind to targets, improving structure-based therapeutic development.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Related Experiment Videos

Last Updated: Feb 17, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Macrocycles are a vital therapeutic class facing computational modeling challenges.
  • Existing methods struggle with sampling bioactive conformations and predicting binding modes.
  • These limitations hinder structure-based drug discovery for macrocyclic therapeutics.

Purpose of the Study:

  • To develop an improved computational docking protocol for macrocycles.
  • To enhance the accuracy of predicting macrocycle binding modes and conformations.
  • To overcome limitations in current macrocycle modeling techniques.

Main Methods:

  • Developed a novel flexible macrocycle docking protocol.
  • Integrated existing Schrödinger macrocycle sampling and small molecule docking technologies.
  • Benchmarked the protocol using an expanded dataset of 240 receptor-macrocycle systems.

Main Results:

  • The new protocol significantly outperforms existing docking tools.
  • Achieved 82% accuracy in recapitulating receptor-bound structures within the top 2 poses.
  • Successfully modeled binding for several clinically relevant macrocyclic compounds.

Conclusions:

  • The developed flexible macrocycle docking protocol shows significant promise for structure-based drug discovery.
  • The method improves the prediction of macrocycle binding poses and conformations.
  • Further research is needed to address challenges like induced-fit effects and strain in macrocycle modeling.